| Health Care Equipment & Supplies Industry | Healthcare Sector | Ms. Li Chen CEO | SSE Exchange | CNE100005PG9 ISIN |
| CN Country | 577 Employees | 12 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Shanghai MicroPort EP Medtech Co., Ltd. is a prominent player in the medical device industry, specifically focusing on the electrophysiological interventional diagnosis and ablation therapy sector. With its roots in research, development, production, and sales, the company has carved a niche in providing high-quality medical devices that cater to various cardiac electrophysiological needs. Originally established as Shanghai Wei Chuang Electrophysiology Medical Technology Co., Ltd., it underwent a name change in April 2016 to better reflect its broadened scope and commitment to innovation. Since its inception in 2010, the company has made significant strides in the medical field and is headquartered in Shanghai, the People's Republic of China.
These state-of-the-art navigation systems are designed for advanced mapping and navigation during electrophysiological procedures, facilitating accurate diagnosis and treatment of cardiac arrhythmias.
These devices play a crucial role in electrophysiology studies, simulating heart rhythms to diagnose heart conditions effectively.
These catheters are used for the ablation of cardiac arrhythmias, utilizing radiofrequency energy to remove or destroy faulty electrical pathways from the heart.
Designed for detailed mapping of the heart's electrical activity, these catheters are essential in identifying the origins of arrhythmias before ablation procedures.
This range of tools facilitates the safe and precise access to the heart chambers via the septal wall, crucial for many diagnostic and therapeutic procedures in electrophysiology.
These catheters are designed for diagnostic purposes, providing high-quality, real-time electrical signals from the heart to guide interventions.